Cyteir Therapeutics (United States)
Home
Cancer’s Vulnerability is Our Strength Learn More About Cyteir Cyteir is a clinical-stage oncology company that is focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Cyteir’s current priority in CYT-0851 development is in combination with capecitabine and
Company details
- Address
- United States
- Website
- cyteir.com
Reviews
No reviews yet.
All reviews of Cyteir Therapeutics (United States) · Write a review
Domain and WHOIS record
- Domain
- cyteir.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 30 May 2012
- Expires
- 30 May 2027
- Record updated
- 10 Sept 2026
- Name servers
- lynn.ns.cloudflare.com, thea.ns.cloudflare.com
- DNSSEC
- Not signed